Kestra Advisory Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,871
| Closed | -$218K | – | 2719 |
|
|
2024
Q3 | $218K | Sell |
8,871
-3,320
| -27% | -$81.7K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $282K | Sell |
12,191
-1,402
| -10% | -$32.4K | ﹤0.01% | 2144 |
|
|
2024
Q1 | $327K | Hold |
13,593
| – | – | ﹤0.01% | 1940 |
|
|
2023
Q4 | $313K | Sell |
13,593
-1,024
| -7% | -$23.6K | ﹤0.01% | 1820 |
|
|
2023
Q3 | $297K | Buy |
14,617
+5,426
| +59% | +$110K | ﹤0.01% | 1660 |
|
|
2023
Q2 | $215K | Sell |
9,191
-12,354
| -57% | -$289K | ﹤0.01% | 1863 |
|
|
2023
Q1 | $501K | Sell |
21,545
-13,878
| -39% | -$323K | 0.01% | 1277 |
|
|
2022
Q4 | $892K | Sell |
35,423
-17,046
| -32% | -$429K | 0.01% | 1108 |
|
|
2022
Q3 | $1.39M | Buy |
52,469
+1,448
| +3% | +$38.2K | 0.01% | 820 |
|
|
2022
Q2 | $1.48M | Sell |
51,021
-6,626
| -11% | -$192K | 0.02% | 790 |
|
|
2022
Q1 | $1.99M | Buy |
57,647
+8,757
| +18% | +$302K | 0.02% | 681 |
|
|
2021
Q4 | $2.14M | Buy |
48,890
+22,968
| +89% | +$1.01M | 0.02% | 653 |
|
|
2021
Q3 | $1.32M | Buy |
25,922
+7,584
| +41% | +$385K | 0.01% | 877 |
|
|
2021
Q2 | $954K | Buy |
18,338
+3,194
| +21% | +$166K | 0.01% | 970 |
|
|
2021
Q1 | $692K | Buy |
15,144
+3,617
| +31% | +$165K | 0.01% | 1036 |
|
|
2020
Q4 | $541K | Buy |
+11,527
| New | +$541K | 0.01% | 1168 |
|